INSPIRE NEWS

Inspire Newsroom

October 19, 2023

Inspire is pleased to announce the hiring of Alya Sherman to the position of Vice President of Business Development to support the company’s growing offerings in healthcare advertising. 

October 11, 2023
A poster presentation at IgNS 2023 titled “Multifocal Motor Neuropathy (MMN) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patient Journey and Experience: A Qualitative Study” helped illuminate the challenges faced by CIDP and MMN patients. The study, which was a collaboration between Inspire, Takeda Pharmaceuticals, and leading CIDP medical experts Dr. Allen and Dr. Karam, aims to bridge the knowledge gap surrounding CIDP and MMN.
October 5, 2023

Inspire welcomes new hires Laurel Netolicky and Michael Butterfield to the position of Vice President of Business Development, demonstrating the company’s commitment to enhancing its client offerings.

October 3, 2023

Inspire is pleased to welcome Stephen Fabiano as Vice President of Life Sciences Partnerships in Real-World Evidence. Fabiano brings more than a decade of experience in healthcare analytics, where he has worked as an analyst, data scientist, and a sales leader.

October 2, 2023

Patient-centered RWE is increasingly important at every phase of drug development and post-approval marketing. Inspire, the leading patient engagement and real-world evidence platform, will host a webinar on October 12 at 11 a.m. ET – Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases.

September 1, 2023

A presentation at ICPE 2023: The Global Home for the Science of Real-World Evidence titled “Understanding Short Bowel Syndrome via Real-World Data” helped illuminate the challenges faced by short bowel syndrome (SBS) patients. The study, led by Inspire, the leading patient engagement and real-world evidence platform, aims to bridge the knowledge gap surrounding SBS.

July 19, 2023

In a recent episode of The Dr. Raj podcast, Inspire CEO Brian Loew shed light on what sets Inspire apart in the online health community space and underscored the crucial role of the patient voice in healthcare.

June 29, 2023

Inspire is pleased to announce the recent hiring of Stuart (Stu) Greenberg, Ph.D., and Sara Midberry to the position of Vice President of Client Solutions. Their appointments signify Inspire’s commitment to offering industry partners unparalleled expertise in healthcare insights solutions.

May 16, 2023​

Inspire has recently announced a new partnership with the Vasculitis Foundation (VF) to launch a dedicated community for people living with vasculitis and their care partners.

May 8, 2023​

A novel patient-centered real-world evidence study is helping shed new light on a rare condition known as chronic inflammatory demyelinating polyneuropathy (CIDP).

May 3, 2023​

Inspire, the leading patient engagement platform, announced today the launch of its Real-World Evidence (RWE) solutions.

April 5, 2023​

Inspire is excited to announce the hiring of Jennifer Moyer, Robert Ramirez, and Amy DeMaria as the newest members of the leadership team.

March 30, 2023

Demand for cosmetic procedures has risen sharply in the U.S. However, there is a lack of data around specific experiences and unmet needs among diverse populations including Black and transgender individuals.

March 1, 2023

Inspire has partnered with the Autoimmune Association to launch a new community for patients living with autoimmune diseases and their caregivers.

February 25, 2022

Inspire recently published a poster highlighting the power of patient-driven data in advancing the understanding and treatment of rare diseases.

February 4, 2022
A recent publication titled Patient and Caregiver Insights into the Disease Burden of Myelodysplastic Syndrome sheds light on the experiences of patients and their caregivers living with this disease.
March 30, 2021
A recent study conducted by researchers at New York University and the University of Michigan, published in the European Urology Open Science journal, has shown the potential for social media platforms to provide insights into patient experiences during the COVID-19 pandemic.